Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK comparison of Extencilline versus Bicillin L-A in healthy adults
PACTR202608642523757Phase 1Not yet recruiting
- Sponsor
- Laboratoires Delbert
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of benzylpenicillin in bacterial disease (2 arms), sponsored by Laboratoires Delbert. Primary endpoint: Relative bioavailability of benzylpenicillin. Planned start May 2026; status: not yet recruiting.
02
Drugs
benzylpenicillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on PACTR202608642523757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608642523757.